ITRM20050330A1 - Complesso molecolare comprendente arbutina, acido ascorbico, oleuropeina o suoi derivati e relativi usi in campo medico. - Google Patents

Complesso molecolare comprendente arbutina, acido ascorbico, oleuropeina o suoi derivati e relativi usi in campo medico.

Info

Publication number
ITRM20050330A1
ITRM20050330A1 IT000330A ITRM20050330A ITRM20050330A1 IT RM20050330 A1 ITRM20050330 A1 IT RM20050330A1 IT 000330 A IT000330 A IT 000330A IT RM20050330 A ITRM20050330 A IT RM20050330A IT RM20050330 A1 ITRM20050330 A1 IT RM20050330A1
Authority
IT
Italy
Prior art keywords
oleuropeine
derivatives
ascorbic acid
medical field
molecular complex
Prior art date
Application number
IT000330A
Other languages
English (en)
Inventor
Matteo Tutino
Original Assignee
Med Care S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Med Care S R L filed Critical Med Care S R L
Priority to IT000330A priority Critical patent/ITRM20050330A1/it
Priority to US11/922,866 priority patent/US20080274094A1/en
Priority to JP2008517704A priority patent/JP2008546759A/ja
Priority to BRPI0613356-8A priority patent/BRPI0613356A2/pt
Priority to PCT/IT2006/000464 priority patent/WO2006137100A2/en
Priority to KR1020087001927A priority patent/KR20080028960A/ko
Priority to AU2006260484A priority patent/AU2006260484A1/en
Priority to CNA2006800308887A priority patent/CN101247816A/zh
Priority to EP06756322A priority patent/EP1906984A2/en
Publication of ITRM20050330A1 publication Critical patent/ITRM20050330A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000330A 2005-06-24 2005-06-24 Complesso molecolare comprendente arbutina, acido ascorbico, oleuropeina o suoi derivati e relativi usi in campo medico. ITRM20050330A1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT000330A ITRM20050330A1 (it) 2005-06-24 2005-06-24 Complesso molecolare comprendente arbutina, acido ascorbico, oleuropeina o suoi derivati e relativi usi in campo medico.
US11/922,866 US20080274094A1 (en) 2005-06-24 2006-06-19 Molecular Complex Comprising Arbutine, Ascorbic Acid, Oleuropeina or Its Derivatives Thereof and Related Uses In Medical Field
JP2008517704A JP2008546759A (ja) 2005-06-24 2006-06-19 アルブチン、アスコルビン酸、オレウロペインまたはその誘導体を含む分子複合体および医薬分野における関連する使用
BRPI0613356-8A BRPI0613356A2 (pt) 2005-06-24 2006-06-19 complexo molecular compreendendo arbutina, ácido ascórbico, oleuropeìna ou seus derivados e usos relacionados na área médica
PCT/IT2006/000464 WO2006137100A2 (en) 2005-06-24 2006-06-19 Molecular complex comprising arbutine, ascorbic acid, oleuropeina or its derivatives thereof and related uses in medical field
KR1020087001927A KR20080028960A (ko) 2005-06-24 2006-06-19 알부틴, 아스코르브산, 올리유로피나 또는 이의 유도체를포함하는 분자 복합체 및 의약 분야에서의 관련 용도
AU2006260484A AU2006260484A1 (en) 2005-06-24 2006-06-19 Molecular complex comprising arbutine, ascorbic acid, oleuropeina or its derivatives thereof and related uses in medical field
CNA2006800308887A CN101247816A (zh) 2005-06-24 2006-06-19 包含熊果苷,抗坏血酸,橄榄苦苷及其衍生物的分子复合物及其在医药领域的相关应用
EP06756322A EP1906984A2 (en) 2005-06-24 2006-06-19 Molecular complex comprising arbutine, ascorbic acid, oleuropeina or its derivatives thereof and related uses in medical field

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000330A ITRM20050330A1 (it) 2005-06-24 2005-06-24 Complesso molecolare comprendente arbutina, acido ascorbico, oleuropeina o suoi derivati e relativi usi in campo medico.

Publications (1)

Publication Number Publication Date
ITRM20050330A1 true ITRM20050330A1 (it) 2006-12-25

Family

ID=37570846

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000330A ITRM20050330A1 (it) 2005-06-24 2005-06-24 Complesso molecolare comprendente arbutina, acido ascorbico, oleuropeina o suoi derivati e relativi usi in campo medico.

Country Status (9)

Country Link
US (1) US20080274094A1 (it)
EP (1) EP1906984A2 (it)
JP (1) JP2008546759A (it)
KR (1) KR20080028960A (it)
CN (1) CN101247816A (it)
AU (1) AU2006260484A1 (it)
BR (1) BRPI0613356A2 (it)
IT (1) ITRM20050330A1 (it)
WO (1) WO2006137100A2 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2919800B1 (fr) * 2007-08-06 2010-08-27 Biochimie Appliquee Solabia So Compositions cosmetiques et/ou dermatologiques contenant un ester de tyrosol ou d'hydroxytyrosol et d'acide gras insature, et leurs utilisations
EP2179739A1 (en) * 2008-10-23 2010-04-28 Matteo Tutino Compositions comprising vitamins
JP5432504B2 (ja) * 2008-11-19 2014-03-05 コスメテックスローランド株式会社 皮膚外用剤およびその製造方法
EP2570124B1 (en) * 2010-05-14 2016-11-02 Sanidad Y Residencias 21, S.A. Oleuropein compositions for healing wounds and ulcers in elderly people and/or diabetics
IT1406864B1 (it) * 2011-01-10 2014-03-14 Endrici Composizione per il trattamento dell'acne
EP2704728A4 (en) * 2011-05-03 2015-04-22 Dermachip Inc EXPRESSION SIGNATURES OF AGENTS ASSOCIATED WITH SKIN AGING AND GEN NETWORKS
JP6030357B2 (ja) * 2012-07-03 2016-11-24 サンスター株式会社 オレウロペイン含有組成物
JP5730837B2 (ja) * 2012-11-05 2015-06-10 一丸ファルコス株式会社 メラニン生成抑制剤、保湿剤、美白化粧料、美容飲食品
DE102012222970A1 (de) * 2012-12-12 2014-06-12 Henkel Ag & Co. Kgaa Wirkstoffkombination zur Hautaufhellung I
CN108969509A (zh) * 2018-03-02 2018-12-11 重庆大学 酪醇在制备治疗糖尿病并发症糖尿病足的药物中的应用
KR102097264B1 (ko) * 2018-06-12 2020-04-06 코스맥스 주식회사 올레우로페인을 함유하는 두피 강화 및 상태 개선용 화장료 조성물
CN115919884B (zh) * 2023-01-03 2023-12-22 成都大学 一种可掩盖橄榄苦苷苦味的橄榄苦苷-多糖复合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040146539A1 (en) * 2003-01-24 2004-07-29 Gupta Shyam K. Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits
BRPI0417884A (pt) * 2003-12-30 2007-04-27 Med Care S R L composições compreendendo vitaminas e/ou derivados das mesmas, estabilizados com extrato de olea europea e/ou polìmeros de ioneno

Also Published As

Publication number Publication date
CN101247816A (zh) 2008-08-20
WO2006137100A3 (en) 2007-08-02
WO2006137100A2 (en) 2006-12-28
BRPI0613356A2 (pt) 2011-01-04
EP1906984A2 (en) 2008-04-09
JP2008546759A (ja) 2008-12-25
AU2006260484A1 (en) 2006-12-28
KR20080028960A (ko) 2008-04-02
US20080274094A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
BRPI0815773A2 (pt) composto, e, medicamento.
DK2155758T3 (da) Tetrahydrofuro[3,4-d]dioxolanforbindelser til anvendelse i behandlingen af virusinfektioner og cancer
DE602006005475D1 (de) Katheter
DK1721623T3 (da) Absorberende polymersammensætninger, medicinske artikler og fremgangsmåder
CL2008001234A1 (es) Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
BRPI0813455A2 (pt) Derivado de 17beta-ciano-18a-homo-19-nor-androst-4-eno, seu uso e medicamentos contendo este derivado.
DK2046715T3 (da) Substituerede 1,3-diphenylpropanderivater, præparater og anvendelser deraf
PT1849470T (pt) Fármaco anticancro contendo alfa, alfa, alfa-trifluorotimidina e inibidor da timidina-fosforilase
HUE042286T2 (hu) Tûvel szerelt, elõre töltött belövõ fecskendõ
EP2150705A4 (en) PUMP AND PUMP DRIVE
BRPI0821276A2 (pt) Produto, e, uso do produto
DK2419097T3 (da) Farmaceutisk sammensætning omfattende (1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol og metformin og anvendelser deraf i behandling af diabetes
EP2206923A4 (en) ROTOR FOR AN INTERNAL CYLINDER PUMP AND INTERNAL CYCLE PUMP WITH THE ROTOR
BRPI0818690A2 (pt) Derivados de quinazolinediona, sua preparação e seus usos terapêuticos.
DK2051975T3 (da) Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel.
BRPI0715342A2 (pt) Derivados de 6-carboxi-normorfinano, síntese e usos dos mesmos
SI1909843T1 (sl) Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo, in njihova uporaba na farmacevtskem področju
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
SI2116249T1 (sl) Farmacevtski sestavek, ki vsebuje gestagene in/ali estrogene in 5-metil-(6s)-tetrahidrofolat
ATE463496T1 (de) 6-phenyl-1h-imidazoä4, 5-cüpyridin-4-carbonitril- derivate als cathepsin-k- und -s-hemmer
DK1986611T3 (da) Proteinpolymernanopartikler med repeat-sekvens, der eventuelt indeholder aktive stoffer, og fremstilling heraf
ITRM20070394A1 (it) Liposomi asimmetrici e loro usi in campo medico.
DK1742952T3 (da) (Poly)-aminoacetamidderivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelser deraf i terapeutika som anticancermidler
BRPI0913401A2 (pt) pregn-4 eno-21, 17-carbolactonas substituídas no anel c e preparados farmacêuticos contendo as mesmas
ITRM20050393A1 (it) Sistema di rilascio controllato di sostanze farmacologicamente attive, processo di preparazione e impieghi in campo medico.